Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

With the investment, the production capacity will have "a considerable ... the active ingredient in Ozempic and Wegovy. Novo ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

Current developments in the health sector include Novo Nordisk's warning about counterfeit Ozempic in the US, Sandoz's antitrust lawsuit against Amgen, and rising concerns in the biotech industry due ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

As counterfeit Ozempic circulates in the U.S., the Food ... can be harmful when there’s no oversight of their source or production quality, Osborn warned. "When they’re made in unregulated ...

With the investment, the production capacity ... the active ingredient in Ozempic and Wegovy. Novo Nordisk's investment comes as Brazilian pharmaceutical companies are preparing to make a push ...